These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 38723031

  • 1. Arrhythmogenic Manifestations of Chagas Disease: Perspectives From the Bench to Bedside.
    Roman-Campos D, Marin-Neto JA, Santos-Miranda A, Kong N, D'Avila A, Rassi A.
    Circ Res; 2024 May 10; 134(10):1379-1397. PubMed ID: 38723031
    [Abstract] [Full Text] [Related]

  • 2. Chagas cardiomyopathy--where do we stand after a hundred years?
    Biolo A, Ribeiro AL, Clausell N.
    Prog Cardiovasc Dis; 2010 May 10; 52(4):300-16. PubMed ID: 20109600
    [Abstract] [Full Text] [Related]

  • 3. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E2 pathway induced during Trypanosoma cruzi infection.
    Hernández M, Wicz S, Corral RS.
    Phytomedicine; 2016 Nov 15; 23(12):1392-1400. PubMed ID: 27765359
    [Abstract] [Full Text] [Related]

  • 4. The clinical immunology of human Chagas disease.
    Dutra WO, Rocha MO, Teixeira MM.
    Trends Parasitol; 2005 Dec 15; 21(12):581-7. PubMed ID: 16236550
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Trypanosoma cruzi coaxes cardiac fibroblasts into preventing cardiomyocyte death by activating nerve growth factor receptor TrkA.
    Aridgides D, Salvador R, PereiraPerrin M.
    PLoS One; 2013 Dec 15; 8(2):e57450. PubMed ID: 23437390
    [Abstract] [Full Text] [Related]

  • 7. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).
    Tanowitz HB, Machado FS, Jelicks LA, Shirani J, de Carvalho AC, Spray DC, Factor SM, Kirchhoff LV, Weiss LM.
    Prog Cardiovasc Dis; 2009 Dec 15; 51(6):524-39. PubMed ID: 19410685
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chagas heart disease: A contemporary review.
    Velasco A, Morillo CA.
    J Nucl Cardiol; 2020 Apr 15; 27(2):445-451. PubMed ID: 30022404
    [Abstract] [Full Text] [Related]

  • 10. The role of fat on cardiomyopathy outcome in mouse models of chronic Trypanosoma cruzi infection.
    Zaki P, Domingues EL, Amjad FM, Narde MB, Gonçalves KR, Viana ML, de Paula H, de Lima WG, Huang H, Bahia MT, Sherer PE, Dos Santos FM, Weiss LM, Tanowitz HB.
    Parasitol Res; 2020 Jun 15; 119(6):1829-1843. PubMed ID: 32206887
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Confirmation of Chagas' cardiomyopathy following heart transplantation.
    Phan BA, Laflamme MA, Stempien-Otero A, Limaye AP, Buckner FS, Levy WC.
    Heart Vessels; 2006 Sep 15; 21(5):325-7. PubMed ID: 17151822
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe.
    Vannucchi V, Tomberli B, Zammarchi L, Fornaro A, Castelli G, Pieralli F, Berni A, Yacoub S, Bartoloni A, Olivotto I.
    J Cardiovasc Med (Hagerstown); 2015 Dec 15; 16(12):817-23. PubMed ID: 25022923
    [Abstract] [Full Text] [Related]

  • 16. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
    Maya JD, Orellana M, Ferreira J, Kemmerling U, López-Muñoz R, Morello A.
    Biol Res; 2010 Dec 15; 43(3):323-31. PubMed ID: 21249304
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.